2023 | HFSA

Cytokinetics Releases Inaugural Corporate Responsibility Report

Industry News In The News

SOUTH SAN FRANCISCO, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the release of its inaugural Corporate Responsibility Report, outlining the Company's commitment to social and environmental responsibility, ethics and governance and patient and community engagement.

“At Cytokinetics, being a responsible corporate citizen is a natural extension of our company values, and in order for us to be successful, our goals must be aligned to the well-being of our employees and the communities that we serve and in which we operate,” said Robert I. Blum, Cytokinetics’ President and Chief Executive Officer. “Corporate responsibility has always been a fundamental core principle that we apply to our work in advancing potential therapies for those living with diseases of impaired muscle function; our inaugural report highlights our commitments and activities and formalizes our pledge to help ensure our plans and progress continue in accordance with our guiding values.” 

Cytokinetics’ inaugural report focuses on Empowering Lives in the communities it serves and highlights three strategic pillars as a framework for reporting. These pillars are:

  • Keeping patients at the center of our work
  • Advancing a high-integrity, diverse and inclusive culture
  • Supporting sustainable communities